HIV-1 low-level viraemia assessed with 3 commercial real-time PCR assays show high variability

Abstract

The most recent versions of widespread commercial VL assays showed substantial variability at low levels and residual viraemia could not be consistently reproduced. Patient outcome studies comparing residual VL to full suppression are therefore biased when using commercial assays.